Migraine Drugs Pipeline Market Review 2017


Posted May 25, 2017 by raaj0210

Latest Pharmaceutical and Healthcare disease pipeline guide Migraine - Pipeline Review, H1 2017, provides an overview of the Migraine (Central Nervous System) pipeline landscape.

 
Migraine - Pipeline Review, H1 2017 report provides comprehensive information on the therapeutics under development for Migraine, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Migraine and features dormant and discontinued projects.

Inquire for Complete Migraine Pipeline Review H1 2017 Report at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1010754

Description of Report:
Migraine Pipeline Review H1 2017 report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key Companies Analyzed In Report: 4P Therapeutics LLC, Achelios Therapeutics, Acorda Therapeutics, Alder Biopharmaceuticals, Allergan Plc, Amgen, Aralez Pharmaceuticals, Astellas Pharma, Avanir Pharmaceuticals, Biofrontera AG, BioHealthonomics, Charleston Laboratories, Corium International, Eli Lilly and Company, Impel NeuroPharma, InKemia IUCT Group SA, InStar Technologies AS, Ionis Pharmaceuticals, Klaria Pharma Holding AB, Medestea Research & Production SpA, Merck & Co, Monosol Rx LLC, NAL Pharmaceuticals Ltd, Promius Pharma LLC, RedHill Biopharma Ltd, Revance Therapeutics, Shin Nippon Biomedical Laboratories Ltd, Suda Ltd, Teva Pharmaceutical Industries Ltd, TheraJect, Tonix Pharmaceuticals Holding Corp, Trevena, Trigemina, TrioxBio, Vertex Pharmaceuticals, Xenon Pharmaceuticals, Zosano Pharma Corp.

Get Discount on Report at http://www.reportsnreports.com/contacts/discount.aspx?name=1010754 (This report is available at up to 25% Discount till June 02nd 2017).

Scope: The report provides a snapshot of the global therapeutic landscape of Migraine. The report reviews pipeline therapeutics for Migraine by companies and universities/research institutes based on information derived from company and industry-specific sources. The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages. The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities. The report reviews key players involved Migraine therapeutics and enlists all their major and minor projects. The report assesses Migraine therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report summarizes all the dormant and discontinued pipeline projects. The report reviews latest news related to pipeline therapeutics for Migraine
Report helps to Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies. Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. Identify and understand important and diverse types of therapeutics under development for Migraine. Identify potential new clients or partners in the target demographic. Develop strategic initiatives by understanding the focus areas of leading companies. Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics. Devise corrective measures for pipeline projects by understanding Migraine pipeline depth and focus of Indication therapeutics. Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Direct Purchase This Report at http://www.reportsnreports.com/purchase.aspx?name=1010754 .

Major Table OF Content
• Number of Products under Development for Migraine, H1 2017 14
• Number of Products under Development for Migraine - Comparative Analysis, H1 2017 15
• Number of Products under Development by Companies, H1 2017
• Number of Products under Development by Companies, H1 2017 (Contd 1)
• Number of Products under Development by Companies, H1 2017 (Contd 2)
• Number of Products under Investigation by Universities/Institutes, H1 2017
• Comparative Analysis by Late Stage Development, H1 2017
• Comparative Analysis by Clinical Stage Development, H1 2017
• Comparative Analysis by Early Stage Development, H1 2017
• Products under Development by Companies, H1 2017
• Products under Development by Companies, H1 2017 (Contd 1)
• Products under Development by Companies, H1 2017 (Contd 2)
• Products under Investigation by Universities/Institutes, H1 2017

About Us:
Reportsnreports.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Contact Us:
Ritesh Tiwari
2nd Floor, Metropole,
Bund Garden Road,
Pune – 411001,
India.
Tel: + 1 888 391 5441
E-mail: [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By ReportsnReports
Website ReportsnReports
Business Address Pune
Country India
Categories Biotech , Health , Medical
Tags drugs , migraine , pipelien , therapeutics
Last Updated May 25, 2017